Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

DOUBLE-STRANDED RNA DEPENDENT PROTEIN KINASE DERIVED PEPTIDES TO PROMOTE PROLIFERATION OF CELLS AND TISSUES IN A CONTROLLED MANNER

  • Read more about DOUBLE-STRANDED RNA DEPENDENT PROTEIN KINASE DERIVED PEPTIDES TO PROMOTE PROLIFERATION OF CELLS AND TISSUES IN A CONTROLLED MANNER
US Patent 6,326,466
Filed on 1999-07-23

Method of Assessing MHC Class I Expression and Proteins Capable of Modulation Class I Expression

  • Read more about Method of Assessing MHC Class I Expression and Proteins Capable of Modulation Class I Expression
US Application 09/215,712
Filed on 1998-12-18

Methods of Assesing MHC Class I Expression and Proteins Capable of Modulation Class I Expression

  • Read more about Methods of Assesing MHC Class I Expression and Proteins Capable of Modulation Class I Expression
US Application 09/215,989
Filed on 1998-12-18

Methods Of Inhibiting The Growth of Cells Bearing LewisY Antigens Useing B1,B3, or B5 Targeted Immunoconjugates

  • Read more about Methods Of Inhibiting The Growth of Cells Bearing LewisY Antigens Useing B1,B3, or B5 Targeted Immunoconjugates
US Patent 6,287,562
Filed on 1999-01-08

Cyanovirin Conjugates And Matrix-Anchored Cyanovirin And Related Compositions And Methods of Use

  • Read more about Cyanovirin Conjugates And Matrix-Anchored Cyanovirin And Related Compositions And Methods of Use
US Application 09/267,447
Filed on 1999-03-12

JANUS FAMILY KINASES AND IDENTIFICATION OF IMMUNE MODULATORS (JAK-3)

  • Read more about JANUS FAMILY KINASES AND IDENTIFICATION OF IMMUNE MODULATORS (JAK-3)
US Application 09/226,540
Filed on 1999-01-06

JANUS FAMILY KINASES AND IDENTIFICATION OF IMMUNE MODULATORS (JAK-3)

  • Read more about JANUS FAMILY KINASES AND IDENTIFICATION OF IMMUNE MODULATORS (JAK-3)
US Application 09/226,541
Filed on 1999-01-06

NUCLEIC ACID ENCODING MESOTHELIN, A DIFFERENTIATION ANTIGEN PRESENT ON MESOTHELIUM, MESOTHELIOMAS AND OVARIAN CANCERS

  • Read more about NUCLEIC ACID ENCODING MESOTHELIN, A DIFFERENTIATION ANTIGEN PRESENT ON MESOTHELIUM, MESOTHELIOMAS AND OVARIAN CANCERS
US Patent 6,153,430
Filed on 1998-12-17

Oligodeoxyribonucleotides Comprising O6-Benzylguanines and Their Use

  • Read more about Oligodeoxyribonucleotides Comprising O6-Benzylguanines and Their Use
Patent Cooperation Treaty
PCT/US1999/002963
Filed on 1999-02-12

HUMAN PROSTATIC CELL LINES IMMORTALIZED BY ADENOVIRUS 12-SIMIAN VIRUS 40 (AD12/SV40) HYBRID VIRUS

  • Read more about HUMAN PROSTATIC CELL LINES IMMORTALIZED BY ADENOVIRUS 12-SIMIAN VIRUS 40 (AD12/SV40) HYBRID VIRUS
US Patent 5,814,452
Filed on 1997-02-25

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 1527
  • Page 1528
  • Page 1529
  • Page 1530
  • Page 1531
  • Page 1532
  • Page 1533
  • Page 1534
  • Page 1535
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health